Embecta (MEX:EMBC) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


MEX:EMBC Embecta Corp MEX:EMBC
53 GF Score
Price MXN497.96
GF Value MXN2,040.03
! 6 Warning Signs
View Full Analysis

What is Embecta Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Embecta's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

MEX:EMBC vs PDEX, STXS, SMTI: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Embecta's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Embecta's Margin of Safety % (DCF Earnings Based) falls into.


MEX:EMBC
53GF Score
Embecta Corp MEX:EMBC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Embecta (MEX:EMBC) Overvalued in 2026?

Based on GuruFocus' analysis, Embecta stock appears to be undervalued. The current stock price of MXN497.96 is trading 75.6% below its estimated GF Value™ of MXN2,040.03.

Key valuation signals for MEX:EMBC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: MXN2,040.03 vs. price of MXN497.96 (75.6% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the MEX:EMBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embecta Business Description

Other Exchanges EMBC:USAJX7:Germany
Address 300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
53GF Score

Get the complete analysis for MEX:EMBC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN497.96
Price
MXN2,040.03
GF Value